Peter Korošec (Avtor), Thilo Jakob (Avtor), Harfi Harb (Avtor), Robert Heddle (Avtor), Sarah Karabus (Avtor), Ricardo de Lima Zollner (Avtor), Julij Gyula Šelb (Avtor), Bernard Yu-Hor Thong (Avtor), Fares Zaitoun (Avtor), David B. K. Golden (Avtor), Michael Levin (Avtor)

Povzetek

Venom immunotherapy is the standard of care for people with severe reactions and has been proven to reduce risk of future anaphylactic events. There is a moral imperative to ensure production, supply and worldwide availability of locally relevant, registered, standardized commercial venom extracts for diagnosis and treatment. Insects causing severe immediate allergic reactions vary by region worldwide. The most common culprits include honeybees (Apis mellifera), social wasps including yellow jackets (Vespula and Dolichovespula), paper wasps (Polistes) and hornets (Vespa), stinging ants (Solenopsis, Myrmecia, Pachycondyla, and Pogonomyrmex), and bumblebees (Bombus). Insects with importance in specific areas of the world include the Australian tick (Ixodes holocyclus), the kissing bug (Triatoma spp), horseflies (Tabanus spp), and mosquitoes (Aedes, Culex, Anopheles). Reliable access to high quality venom immunotherapy to locally relevant allergens is not available throughout the world. Many current commercially available therapeutic vaccines have deficiencies, are not suitable for, or are unavailable in vast areas of the globe. New products are required to replace products that are unstandardized or inadequate, particularly whole-body extract products. New products are required for insects in which no current treatment options exist. Venom immunotherapy should be promoted throughout the world and the provision thereof be supported by health authorities, regulatory authorities and all sectors of the health care service.

Ključne besede

hornet;bumblebee;mosquitoes;venom immunotherapy;

Podatki

Jezik: Angleški jezik
Leto izida:
Tipologija: 1.02 - Pregledni znanstveni članek
Založnik: Elsevier
UDK: 616-097
COBISS: 2048568945 Povezava se bo odprla v novem oknu
ISSN: 1939-4551
Št. ogledov: 1112
Št. prenosov: 631
Ocena: 0 (0 glasov)
Metapodatki: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Ostali podatki

Sekundarne ključne besede: sršen;čmrlj;komarji;imunoterapija z živalskimi strupi;Allergy and immunology;Venoms;Hymenoptera;Bee venoms;Wasp venoms;Insecta;Ants;Desensitization, immunologic;Alergija in imunologija;Živalski strupi;Kožekrilci;Čebelji strupi;Osji strupi;Insekti;Mravlje;Imunološka desenzibilizacija;
Komentar vira: Soavtor iz Slovenije: Julij Selb; "Korosec and Jakob were joint first authors" --> str. 1; Nasl. z nasl. zaslona; Opis vira z dne 8. 11. 2019; Št. članka: 10067;
Strani: str. 1-11
Letnik: ǂVol. ǂ12
Zvezek: ǂiss. ǂ10
Čas izdaje: Oct. 2019
DOI: 10.1016/j.waojou.2019.100067
ID: 12038966